CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid sparing inhibitor of prostaglandin mediated inflammation, announced today that preliminary safety data ...

The Olympia City Council’s study session on Tuesday was interrupted by members of the public during interim Police Chief ...

In the early days of SU and Claude’s partnership, concerns about security and transparency have grown. The D.O. outlines the ...

Pancreatic cancer multi-center clinical trial in U.S. is underway; patient recruitment expected to be completed by the end of ...

The presentation software market is expanding as businesses, educational institutions, and media organizations adopt cloud-based, AI-powered tools for interactive, data-driven presentations. Rising ...

PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ...

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the presentation of preclinical ...

Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant ...

Durango residents are angry about Flock Safety cameras that have been deployed around the city and are calling for Durango ...

Gov. Ron DeSantis’s push to regulate AI has received pushback from President Donald Trump, who plans to clamp down on states ...

Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and ...

BNY has expanded its enterprise AI platform, Eliza, through a new integration with Google Cloud’s Gemini Enterprise, marking ...